P/E Ratio

The P/E ratio of 29.1x means that investors are currently paying $29.10 for every $1 of Align Technology’s annual earnings per share.

This is above the healthcare sector median of 24.6x and places the stock in the 74th percentile among its sector peers, indicating a higher valuation than most comparable companies. Both the year-over-year and quarter-over-quarter changes are listed as N/A, and no trend data for the last eight quarters is available, so no directional shift can be assessed. The high relative P/E suggests a premium valuation, but the absence of trend information makes it unclear whether the multiple is expanding or contracting, creating an ambiguous risk profile. This metric neither strongly contradicts nor fully supports the NEUTRAL verdict, as the elevated level alone does not confirm overvaluation or opportunity without historical context.

Frequently Asked Questions

Closest Sector Peers